LoQus23 Therapeutics
LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease.
London, UK
Total raised
€8.3M
€8,321,139
Funding rounds
1
Investors
2
distinct backers
Active since
2021-11
latest 2021-11
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood16
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-11-23 | Seed | €8.3M | Dementia Discovery Fund,Novartis Venture Fund | View deal → |